Stocks That Hit 52-Week Lows On Tuesday
Tuesday's session saw 325 companies set new 52-week lows.
10 Health Care Stocks Whale Activity In Today’s Session
This whale alert can help traders discover the next big trading opportunities.
Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner.
Barron’s Top Weekend Stock Picks: AMD, Ford, Accenture And Should Tesla CEO Elon Musk Be Replaced?
Benzinga reviews this weekend's top stories covered by Barron's, here are the articles investors need to read.
Why Avaya Holdings Shares Are Trading Lower By 62%? Here Are 62 Stocks Moving In Friday’s Mid-Day Session
Gainers
Allarity Therapeutics, Inc. (NASDAQ: ALLR) gained 240% to $0.90. Allarity Therapeutics, last month, posted a Q3 loss of $0.68 per share.
12 Health Care Stocks Moving In Friday’s Intraday Session
Gainers Allarity Therapeutics (NASDAQ:ALLR) stock rose 164.2% to $0.7 during Friday’s regular session. As of 12:30 EST, this…
Guardant Health, Novavax And Some Other Big Stocks Moving Lower In Today’s Pre-Market Session
U.S. stock futures traded lower this morning. Here are some big stocks recording losses in today’s pre-market trading session.
Tesla, Apple, Novavax, Adobe, Guardant Health: Why These 5 Stocks Are Drawing Investors’ Attention Today
Major Wall Street indices closed over 2% lower on Thursday after U.S. retail sales saw their steepest drop in close to a year last month, suggesting consumers are reining in spending around the holidays.
After-Hours Action: What’s Going On With Guardant Health, Exact Sciences Shares?
Guardant Health Inc (NASDAQ: GH) and Exact Sciences Corp (NASDAQ: EXAS) shares are moving in different directions in Thursday's after-hours session. Here's a look at what's going on.
Guardant Health Announces Collaboration With AstraZeneca To Develop Companion Diagnostic To Identify Patients With ESR1-mutated Metastatic Breast Cancer
Guardant Health, Inc. (NASDAQ:GH), a leading precision oncology company, announced today it has entered into a collaboration with AstraZeneca to pursue the development, regulatory approval and commercialization of the